Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Jan 11, 2017
    FTC, N.Y. AG Sue Prevagen Marketers for Deceptive Marketing Claims; Company ‘Vehemently Disagrees’
  • Jan 10, 2017
    NAD Recommends Company Modify Product Name, Discontinue Hair-Growth Claims
  • Jan 10, 2017
    Bill Introduced in Indiana House Requires Cost Reporting for High-priced Drugs
  • Jan 7, 2017
    District Court Dismisses FCA Case Against Teva
  • Jan 4, 2017
    Former Compounding Company Sales Manager Pleads Guilty to Conspiring To Defraud FDA
  • Jan 3, 2017
    FDA Plans Studies on Consumer and Physician Identification and Response to ‘Bad Ads’
  • Jan 3, 2017
    Sears Settles California Supplement Case
  • Dec 29, 2016
    FCC Finds Pharmacy Faxes Are Unsolicited Ads
  • Dec 28, 2016
    OPDP Issues Two More Untitled Letters Citing Videos Promoting Investigational Products
  • Dec 22, 2016
    Do Recent Untitled Letters Signal New DTC TV Ad Standard?
  • More

Good Clinical Practice

  • Jul 27, 2017
    SACHRP Proposes Guidance for Use of ‘Benign Behavioral Research’ Exemption
  • Jul 27, 2017
    Review of Common Rule Revisions Continues With No Indication of Substantive Changes
  • Jul 27, 2017
    Expanded Access Navigator Launched
  • Jul 24, 2017
    FDA Issues Guidance Allowing IRBs To Waive or Alter Informed Consent for Minimal Risk Research
  • Jul 24, 2017
    IBD Clinical Trial Community Launched
  • Jul 20, 2017
    ClinicalTrials.gov Needs Better Screening To Find ‘Pay-to-Participate’ Stem Cell Studies
  • Jul 20, 2017
    Small Study Finds Insurance Coverage for Clinical Trials Jumped With ACA Mandate
  • Jul 20, 2017
    Sharing Trial Data Will Take Time and Money
  • Jul 14, 2017
    FDA To Conduct Public Workshop Sept. 8 on Pediatric Trial Design and Modeling
  • Jul 14, 2017
    House FDA Reauthorization Act Includes Clinical Trial Provisions
  • More

U.S. Food Labeling

  • Jan 31,2011
    Food Industry Unveils FOP Labeling Program
  • Jan 31,2011
    FSIS Issues Final Rule for Nutrition Labeling of Raw Meat and Poultry Products
  • Jan 31,2011
    GAO Report Takes FDA to Task over Its Handling Of Structure/Function Claims in Foods
  • Jan 31,2011
    Kellogg Agrees To Settle Rice Krispies Lawsuit
  • Jan 31,2011
    FDA Urged To Require Health Messages on Labels Of Sugar-Sweetened Beverages
  • Dec 31,2010
    FTC Reaches Settlement with NBTY over Deceptive DHA Health Claims in Kids' Vitamins
  • Dec 31,2010
    FDA Seeks To Amend Health Claim on Phytosterols
  • Dec 31,2010
    Jury Rejects POM Claims Against Tropicana
  • Dec 31,2010
    FDA Warns Industry about Using Undeclared Drug Ingredients in Dietary Supplements
  • Dec 31,2010
    Dannon Settles with FTC over Health Claims for Activia Yogurt and DanActive Drink
  • More

FDA Regulation & Enforcement

  • Nov 27, 2019
    Federal Court in Boston Overturns Some Verdicts Against Four Insys Therapeutics Executives
  • Nov 27, 2019
    Consumer Group Seeks Enforcement Action Against Multiple Supplement Firms
  • Nov 27, 2019
    OPDP Issues Seventh Untitled Letter for 2019
  • Nov 22, 2019
    Major Statement Rule Pushed Back Again
  • Nov 22, 2019
    Co-Pay Fund To Pay $4 Million To Settle Kickback Charges
  • Nov 22, 2019
    W.Va. Files Suit Against Two Opioid Makers
  • Nov 21, 2019
    DOJ: South Dakota Surgeon, Physician-Owned Distributorships Created ‘Multiple’ Illegal Kickback Schemes
  • Nov 21, 2019
    FSIS Opens Docket on COOL Labeling Petition, Claims for Beef Products
  • Nov 20, 2019
    Group Urges FDA-FTC Warning Letters Over Fertility Supplement Marketing
  • Nov 19, 2019
    Study Finds Disclosures Don’t Change Physician Perception of Off-label Information
  • More

Medical Devices

  • Sep 12, 2013
    Enforcement of ‘Face-to-Face Encounter’ Mandate for Some Covered DME Items Is Delayed by CMS
  • Sep 6, 2013
    CDRH Drafts SOP for Issuing Immediate Guidance
  • Sep 4, 2013
    Court: No Preemption for IDE Device Used Outside Study
  • Aug 31, 2013
    CDRH Mulls Pilot Program for ‘Mid-Cycle’ IDE Reviews
  • Aug 28, 2013
    Draft Guidance Addresses How GLPs Apply to Nonclinical Laboratory Studies
  • Aug 22, 2013
    Nonprofit Group Wants To Develop Benchmarks for Device Cybersecurity
  • Aug 15, 2013
    FDA Finalizes Guidance on Radio Frequency Wireless Technology for Devices; Focus on EMC, Coexistence
  • Jul 30, 2013
    CDRH Announces IT Improvements for IDEs, EUAs
  • Jul 29, 2013
    FDA To Hold Public Workshop on Patient Preferences
  • Jul 25, 2013
    House Bill Would Exempt FDA User Fees From Sequestration; Trade Associations Urge Passage
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.